Related Experiment Videos
A complementation analysis by parasexual recombination of Candida albicans morphological mutants
1Departamento de Microbiología II, Facultad de Farmacia, Universidad Complutense, Madrid, Spain.
Journal of General Microbiology
|June 1, 1988
Summary
Benomyl treatment induced morphological mutants in Candida albicans, altering its dimorphism. Genetic analysis identified two key genes controlling the yeast-to-mycelium transition.
Area of Science:
- Mycology
- Cell Biology
- Genetics
Background:
- Candida albicans exhibits dimorphism, switching between yeast and filamentous forms.
- This morphological transition is crucial for its pathogenicity and survival.
- Understanding the genetic control of dimorphism is vital for developing targeted therapies.
Purpose of the Study:
- To investigate the effects of benomyl on Candida albicans morphogenesis.
- To identify and genetically characterize mutants with altered dimorphic transitions.
- To elucidate the genes involved in regulating Candida albicans dimorphism.
Main Methods:
- Benomyl treatment of Candida albicans strains to induce morphological mutants.
- Isolation and characterization of yeast (Y) and rough colony (R) phenotypes.
- Genetic complementation analysis using protoplast fusion with nutritional and conditional lethal markers.
Main Results:
- Benomyl induced stable morphological mutants with altered morphogenesis, unable to bud or form blastospores (Y-phenotype) and growing as filaments (R-phenotype).
- Genetic complementation analysis revealed two distinct complementation groups, indicating mutations in two relevant genes.
- Protoplast fusion crosses between complementing mutants restored wild-type morphology (oval yeast cells, smooth colonies), while non-complementing crosses retained mutant phenotypes.
Conclusions:
- Benomyl is a potent inducer of heritable morphological changes in Candida albicans.
- Two genes have been identified as critical for regulating the dimorphic transition from blastospores to mycelium.
- These findings provide insights into the genetic basis of Candida albicans dimorphism and potential therapeutic targets.